Skip to content

2011 TVL Accelerator Company, Xeris Pharmaceuticals started trading as (XERS) on June 21!

Posted in TVL Investment Competition

Spring 2011 TVL Accelerator Company, Xeris Pharmaceuticals started trading as (XERS) on June 21!

Xeris Pharmaceuticals (XERS) intends to raise $75 million in an IPO of its common stock on the Nasdaq Exchange.  The company is developing a variety of injectable and continuous treatments for diabetic conditions. XERS has had apparent Phase 3 trial success and is planning to ramp up commercialization efforts for the latter half of 2019. [Seeking Alpha: Xeris Pharmaceuticals (XERS)]

Stay updated on Xeris Pharmaceuticals (XERS) as we continue to follow their journey through the IPO!

Nasdaq: https://www.nasdaq.com/symbol/xers

Xeris Pharmaceuticals: https://www.xerispharma.com/

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Skip to toolbar